Elanco Animal Health Inc 4

Jeffrey N. Simmons, President, CEO and Director of Elanco Animal Health Inc. (ELAN), received 113.4857 deferred stock units as a deferred compensation award.

On July 24, 2026, Elanco Animal Health Inc. President, CEO and Director Jeffrey N. Simmons was credited with 113.4857 deferred stock units at a deemed price of $24.91 per unit, representing an aggregate value of roughly $2,828 under the company’s Executive Deferral and Stock Match Plan; these units are a form of non-cash, deferred compensation that will settle in either cash or common stock following termination of employment or in a specified future year, and they increase his deferred equity-based exposure to the company rather than reflecting an open-market purchase or sale.

Filing Facts

CIK

1739104

Ticker

ELAN

Form

4

Source Type

fda

Accession

0001479079-26-000035

Alert Tier

4